Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-19

Clinical Trial Update: Relationship of Haptoglobin Phenotype to Vascular Function and Response to Vitamin E Supplementation in Patients With Diabetes Mellitus Type 2: The EVAS Trial [NA]

View source ↗

Summary

This clinical trial update discusses the EVAS trial, which examines how haptoglobin phenotype influences vascular function and response to Vitamin E in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin E (tocopherol)

Snippet

Sponsor: Tan Tock Seng Hospital | Conditions: Diabetes Mellitus | NA | Status: UNKNOWN